(P-1494) Risk of immune thrombocytopenia after second dose of a measles containing vaccine

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Ousseny Zerbo, PhD

Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, CA, United States

Co-Author(s)

SM

Sharareh Modaressi, MD, MPH

Data Analyst
Kaiser Permanente Vaccine Study Center
Oakland, California, United States
BF

Bruce Fireman, MA

Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
PR

Pat Ross, BA

Research Associate
Kaiser Permanente Vaccine Study Center
Oakland, CA, United States
KG

Kristin Goddard, MpH

Sr. Research Project Manager
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
JN

Jennifer Nelson, PhD

Kaiser Permanente Washington Health Research Institute
Seattle, Washington, United States
JG

Jason Glanz, PhD

Senior Research Investigator
Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado
Denver, Colorado, United States
Stephanie Irving, MHS (she/her/hers)

Senior Research Associate
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
BL

Bruno Lewin, MD

Clinical Investigator
Kaiser Permanente Department of Research and Evaluation
Pasadena, CA, United States
MD

Malini B. DeSilva, MD, MPH

Senior Research Investigator
HealthPartners Institute
Bloomington, Minnesota, United States
JW

Joshua T.B. Williams, MD

Denver Health
Denver, Colorado, United States
MS

Maria Sundaram, PhD, MSPH

Associate Research Scientist
Marshfield Clinic Research Institute
Marshfield, Wisconsin, United States
Nicola P. Klein, MD, PhD (she/her/hers)

Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States